STERIS STE UNITED STATES — Revenue
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by STERIS in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The official record: STERIS’s 10-K, filed May 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about STERIS's united states — revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is STERIS's UNITED STATES — revenue?
- STERIS (STE) reported UNITED STATES — revenue of $1.15B in Q1 2026.
- How has STERIS's UNITED STATES — revenue changed year-over-year?
- STERIS's UNITED STATES — revenue increased by 6.2% year-over-year, from $1.08B to $1.15B.
- What is the long-term trend for STERIS's UNITED STATES — revenue?
- Over 4 years (2022 to 2026), STERIS's UNITED STATES — revenue has grown at a 10.1% compound annual growth rate (CAGR), from $2.94B to $4.33B.
- What does UNITED STATES — revenue mean?
- This metric captures the total gross income generated from the sale of sterilization services, decontamination equipment, and related supplies within the United States geographic segment. It serves as a primary indicator of market demand and the company's competitive position in the domestic healthcare and biopharma sectors. Growth in this figure reflects successful market penetration, pricing power, or increased volume in infection prevention services.